• Je něco špatně v tomto záznamu ?

High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance

A. Skalova, I. Leivo, H. Hellquist, A. Agaimy, RHW. Simpson, G. Stenman, V. Vander Poorten, JA. Bishop, A. Franchi, JC. Hernandez-Prera, D. Slouka, SM. Willems, KD. Olsen, A. Ferlito

. 2021 ; 28 (3) : 107-118. [pub] 2021May01

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018647

High-grade transformation (HGT) or dedifferentiation has been described in a variety of salivary gland carcinomas, including acinic cell carcinoma, secretory carcinoma, adenoid cystic carcinoma, epithelial-myoepithelial carcinoma, polymorphous adenocarcinoma, low-grade mucoepidermoid carcinoma, and hyalinizing clear cell carcinoma. High-grade (HG) transformed tumors are composed of a conventional low-grade component characterized by specific microscopic and immunohistochemical features for the given entity, intermingled with or juxtaposed to areas of HG morphology. This is usually either poorly differentiated adenocarcinoma, carcinoma not otherwise specified, or undifferentiated carcinoma, in which the original line of differentiation is lost. The HG component is composed of solid nests of anaplastic cells with large vesicular pleomorphic nuclei, prominent nucleoli, and abundant cytoplasm. Frequent mitoses and extensive necrosis may be present. The Ki-67 labeling index is consistently higher in the HG component. The molecular genetic mechanisms responsible for HGT of salivary gland carcinomas are largely unknown, though p53 inactivation and human epidermal growth factor receptor 2 overexpression and/or gene amplification have been demonstrated in the HG component in a few examples, the frequency varies for each histologic type. Salivary gland carcinomas with HGT are more aggressive than conventional carcinomas, with a higher local recurrence rate and a poorer prognosis. They have a high propensity for cervical lymph node metastasis suggesting a need for a wider resection and neck dissection. HGT of salivary gland carcinoma can occur either at initial presentation or less commonly at the time of recurrence, sometimes following postoperative radiotherapy. The potential for HGT in almost any type of salivary gland carcinoma warrants a thorough sampling of all salivary gland malignancies to prevent oversight of a HG component.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018647
003      
CZ-PrNML
005      
20210830100239.0
007      
ta
008      
210728s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/PAP.0000000000000298 $2 doi
035    __
$a (PubMed)33825717
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Skalova, Alena $u Departments of Pathology
245    10
$a High-grade Transformation/Dedifferentiation in Salivary Gland Carcinomas: Occurrence Across Subtypes and Clinical Significance / $c A. Skalova, I. Leivo, H. Hellquist, A. Agaimy, RHW. Simpson, G. Stenman, V. Vander Poorten, JA. Bishop, A. Franchi, JC. Hernandez-Prera, D. Slouka, SM. Willems, KD. Olsen, A. Ferlito
520    9_
$a High-grade transformation (HGT) or dedifferentiation has been described in a variety of salivary gland carcinomas, including acinic cell carcinoma, secretory carcinoma, adenoid cystic carcinoma, epithelial-myoepithelial carcinoma, polymorphous adenocarcinoma, low-grade mucoepidermoid carcinoma, and hyalinizing clear cell carcinoma. High-grade (HG) transformed tumors are composed of a conventional low-grade component characterized by specific microscopic and immunohistochemical features for the given entity, intermingled with or juxtaposed to areas of HG morphology. This is usually either poorly differentiated adenocarcinoma, carcinoma not otherwise specified, or undifferentiated carcinoma, in which the original line of differentiation is lost. The HG component is composed of solid nests of anaplastic cells with large vesicular pleomorphic nuclei, prominent nucleoli, and abundant cytoplasm. Frequent mitoses and extensive necrosis may be present. The Ki-67 labeling index is consistently higher in the HG component. The molecular genetic mechanisms responsible for HGT of salivary gland carcinomas are largely unknown, though p53 inactivation and human epidermal growth factor receptor 2 overexpression and/or gene amplification have been demonstrated in the HG component in a few examples, the frequency varies for each histologic type. Salivary gland carcinomas with HGT are more aggressive than conventional carcinomas, with a higher local recurrence rate and a poorer prognosis. They have a high propensity for cervical lymph node metastasis suggesting a need for a wider resection and neck dissection. HGT of salivary gland carcinoma can occur either at initial presentation or less commonly at the time of recurrence, sometimes following postoperative radiotherapy. The potential for HGT in almost any type of salivary gland carcinoma warrants a thorough sampling of all salivary gland malignancies to prevent oversight of a HG component.
650    _2
$a nádorové biomarkery $x genetika $7 D014408
650    _2
$a karcinom $x genetika $x patologie $7 D002277
650    _2
$a dediferenciace buněk $x fyziologie $7 D054337
650    _2
$a nádorová transformace buněk $x genetika $x patologie $7 D002471
650    _2
$a lidé $7 D006801
650    _2
$a receptor erbB-2 $x genetika $7 D018719
650    _2
$a nádory slinných žláz $x genetika $x patologie $7 D012468
650    _2
$a slinné žlázy $x patologie $7 D012469
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Leivo, Ilmo $u Institute of Biomedicine, Pathology, University of Turku $u Department of Pathology, Turku University Hospital, Turku, Finland
700    1_
$a Hellquist, Henrik $u Department of Biomedical Sciences and Medicine, Epigenetics and Human Disease, University of Algarve, Faro, Portugal
700    1_
$a Agaimy, Abbas $u Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen, Germany
700    1_
$a Simpson, Roderick H W $u Department of Anatomical Pathology, University of Calgary, Calgary, AB, Canada
700    1_
$a Stenman, Göran $u Department of Pathology, Sahlgrenska Center for Cancer Research, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
700    1_
$a Vander Poorten, Vincent $u Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven $u Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium
700    1_
$a Bishop, Justin A $u Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX
700    1_
$a Franchi, Alessandro $u Department of Translational Research and of New Technologies in Medicine and Surgery, University of Pisa, Pisa
700    1_
$a Hernandez-Prera, Juan C $u Department of Pathology, Moffitt Cancer Center, Tampa, FL
700    1_
$a Slouka, David $u Otorhinolaryngology, Charles University Faculty of Medicine in Plzen, Plzen, Czech Republic
700    1_
$a Willems, Stefan M $u Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands
700    1_
$a Olsen, Kerry D $u Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN
700    1_
$a Ferlito, Alfio $u International Head and Neck Scientific Group, Padua, Italy
773    0_
$w MED00000158 $t Advances in anatomic pathology $x 1533-4031 $g Roč. 28, č. 3 (2021), s. 107-118
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33825717 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100239 $b ABA008
999    __
$a ok $b bmc $g 1689673 $s 1139093
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 3 $d 107-118 $e 2021May01 $i 1533-4031 $m Advances in anatomic pathology $n Adv Anat Pathol $x MED00000158
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace